Projected Prognosis as a Predictor of Short-term Outcome After Treatment of Minor Musculoskeletal Injuries in the Emergency Department

NCT ID: NCT04011917

Last Updated: 2020-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

432 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-15

Study Completion Date

2019-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study describes the caseload treated by the extended scope physiotherapists(ESP) working in the emergency department at Slagelse Hospital.

Patients treated by the ESP during a 3 month period will be included in this study.

Furthermore we aim to assess if ESPs treating patients with minor musculoskeletal injuries in the ED can predict the short-term prognosis of recovery. The prediction is made at hospital discharge using a (-7/+7) numerical rating scale (-7=poor prognosis; 7=best prognosis).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caseload group

Standard care

Intervention Type BEHAVIORAL

Treatment by an extended scope physiotherapist following Standard Operating Procedures.

Prediction group

Standard care

Intervention Type BEHAVIORAL

Treatment by an extended scope physiotherapist following Standard Operating Procedures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard care

Treatment by an extended scope physiotherapist following Standard Operating Procedures.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1 Treated by an ESP for a minor musculoskeletal injury in the emergency room
* 2 Has an email address
* 3 Signed informed consent form

Exclusion Criteria

* 1 A condition that, in the opinion of the investigator, would preclude participation in the study (e.g., not having access to the internet, cognitive impairments etc.)
* 2 Under the influence of drugs or alcohol
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bispebjerg Hospital

OTHER

Sponsor Role collaborator

Slagelse Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian P Olsen, PT, Phd candidate

Role: PRINCIPAL_INVESTIGATOR

Næstved-Slagelse-Ringsted Hospitals

Marius Henriksen, PT, PhD

Role: STUDY_CHAIR

Department of Physical and Occupational Therapy, Bispebjerg-Frederiksberg Hospital

Søren T Skou, PT, PhD

Role: STUDY_CHAIR

Næstved-Slagelse-Ringsted Hospitals and University of Southern Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Emergency Department, Slagelse Hospital

Slagelse, Region Sjælland, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REG-032-2019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.